Anzala, O., J. Sanders, A. Kamali, M. Katende, G. Mutua, E. Ruzagira, G. Stevens, M. Simek and M. Price (2008). "Sensitivity And Specificity Of Hiv Rapid Tests Used For Research And Voluntary Counselling And Testing." East Afr Med J. 85(10): 500-504.



Astronomo, R. and B. D. (2008). "Synthetic Tetramannose Glycoconjugate Antigen For Broadly Neutralizing HIV-1 Antibody 2G12 Elicits Anti-Mannose Antibodies That Selectively Bind Tetramannose But Not The Oligomannose N-Glycans of HIV-1 GP120”." Journal of Biological Chemisty In Preparation.



Astronomo, R. D., H. K. Lee, C. N. Scanlan, R. Pantophlet, C. Y. Huang, I. A. Wilson, O. Blixt, R. A. Dwek, C. H. Wong and D. R. Burton (2008). "A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120." J Virol 82(13): 6359-6368.



Berkley, S. (2008). "HIV vaccine trials in India." Nat Biotechnol 26(5): 495; author reply 496.



Bimber, B. N., A. J. Moreland, R. W. Wiseman, A. L. Hughes and D. H. O'Connor (2008). "Complete characterization of killer Ig-like receptor (KIR) haplotypes in Mauritian cynomolgus macaques: novel insights into nonhuman primate KIR gene content and organization." J Immunol 181(9): 6301-6308.



Buchbinder, S. P., D. V. Mehrotra, A. Duerr, D. W. Fitzgerald, R. Mogg, D. Li, P. B. Gilbert, J. R. Lama, M. Marmor, C. Del Rio, M. J. McElrath, D. R. Casimiro, K. M. Gottesdiener, J. A. Chodakewitz, L. Corey, M. N. Robertson and T. Step Study Protocol (2008). "Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial." Lancet 372(9653): 1881-1893.



Chomba, E., S. Allen, W. Kanweka, A. Tichacek, G. Cox, E. Shutes, I. Zulu, N. Kancheya, M. Sinkala, R. Stephenson, A. Haworth and H. I. V. R. G. Rwanda Zambia (2008). "Evolution of couples' voluntary counseling and testing for HIV in Lusaka, Zambia." J Acquir Immune Defic Syndr 47(1): 108-115.



Coldiron, M. E., R. Stephenson, E. Chomba, C. Vwalika, E. Karita, K. Kayitenkore, A. Tichacek, L. Isanhart, S. Allen and A. Haworth (2008). "The relationship between alcohol consumption and unprotected sex among known HIV-discordant couples in Rwanda and Zambia." AIDS Behav 12(4): 594-603.



Dey, A. K., K. B. David, N. Ray, T. J. Ketas, P. J. Klasse, R. W. Doms and J. P. Moore (2008). "N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virus." Virology 372(1): 187-200.



Dhillon, A. K., R. L. Stanfield, M. K. Gorny, C. Williams, S. Zolla-Pazner and I. A. Wilson (2008). "Structure determination of an anti-HIV-1 Fab 447-52D-peptide complex from an epitaxially twinned data set." Acta Crystallogr D Biol Crystallogr D64(Pt 7): 792-802.



Doores, K. J. and B. G. Davis (2008). "Reagent switchable stereoselective beta(1,2) mannoside mannosylation: OH-2 of mannose is a privileged acceptor." Org Biomol Chem 6(15): 2692-2696.



Dunkle, K. L., L. Greenberg, A. Lanterman, R. Stephenson and S. Allen (2008). "Source of new infections in generalised HIV epidemics – Authors' reply (invited correspondence)." The Lancet 372(9656): 1300-1301.



Dunkle, K. L., R. Stephenson, E. Karita, E. Chomba, K. Kayitenkore, C. Vwalika, L. Greenberg and S. Allen (2008). "New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data." Lancet 371(9631): 2183-2191.



Excler, J. L., S. Kochhar, S. Kapoor, S. Das, J. Bahri, M. D. Ghosh, N. K. Ganguly, A. Nayyar and M. Chataway (2008). "Preparedness for AIDS vaccine trials in India." Indian J Med Res 127(6): 531-538.



Excler, J. L., P. Pitisuttithum, S. Rerks-Ngarm, Y. Shao, L. Zhang, H. Tamashiro, S. Osmanov and W.-U. R. Consultation (2008). "Expanding research capacity and accelerating AIDS vaccine development in Asia." Southeast Asian J Trop Med Public Health 39(4): 766-784.



Fauci, A. S., M. I. Johnston, C. W. Dieffenbach, D. R. Burton, S. M. Hammer, J. A. Hoxie, M. Martin, J. Overbaugh, D. I. Watkins, A. Mahmoud and W. C. Greene (2008). "HIV vaccine research: the way forward." Science 321(5888): 530-532.



Gaucher, D., R. Therrien, N. Kettaf, B. R. Angermann, G. Boucher, A. Filali-Mouhim, J. M. Moser, R. S. Mehta, D. R. Drake, 3rd, E. Castro, R. Akondy, A. Rinfret, B. Yassine-Diab, E. A. Said, Y. Chouikh, M. J. Cameron, R. Clum, D. Kelvin, R. Somogyi, L. D. Greller, R. S. Balderas, P. Wilkinson, G. Pantaleo, J. Tartaglia, E. K. Haddad and R. P. Sekaly (2008). "Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses." J Exp Med 205(13): 3119-3131.



Goepfert, P. A., W. Lumm, P. Farmer, P. Matthews, A. Prendergast, J. M. Carlson, C. A. Derdeyn, J. Tang, R. A. Kaslow, A. Bansal, K. Yusim, D. Heckerman, J. Mulenga, S. Allen, P. J. Goulder and E. Hunter (2008). "Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients." J Exp Med 205(5): 1009-1017.



Gray, K., K. Legg, A. Sharp, N. Mackie, F. Olarinde, C. De Souza, J. Weber and B. Peters (2008). "Participation in two phase II prophylactic HIV vaccine trials in the UK." Vaccine 26(23): 2919-2924.



Greene, J. M., B. J. Burwitz, A. J. Blasky, T. L. Mattila, J. J. Hong, E. G. Rakasz, R. W. Wiseman, K. J. Hasenkrug, P. J. Skinner, S. L. O'Connor and D. H. O'Connor (2008). "Allogeneic lymphocytes persist and traffic in feral MHC-matched mauritian cynomolgus macaques." PLoS One 3(6): e2384.



Grijsen, M. L., S. M. Graham, M. Mwangome, P. Githua, S. Mutimba, L. Wamuyu, H. Okuku, M. A. Price, R. S. McClelland, A. D. Smith and E. J. Sanders (2008). "Screening for genital and anorectal sexually transmitted infections in HIV prevention trials in Africa." Sex Transm Infect 84(5): 364-370.



Groot, F., S. Welsch and Q. J. Sattentau (2008). "Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses." Blood 111(9): 4660-4663.



Guimaraes-Walker, A., N. Mackie, S. McCormack, T. Hanke, C. Schmidt, J. Gilmour, B. Barin, A. McMichael, J. Weber, K. Legg, A. Babiker, P. Hayes, F. Gotch, C. Smith, L. Dally, L. Dorrell, I. Cebere, R. Kay, N. Winstone, S. Moore, N. Goonetilleke, P. Fast and I.-S. Group (2008). "Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers." Vaccine 26(51): 6671-6677.



Harvey, D. J., M. Crispin, C. Scanlan, B. B. Singer, L. Lucka, V. T. Chang, C. M. Radcliffe, S. Thobhani, C. T. Yuen and P. M. Rudd (2008). "Differentiation between isomeric triantennary N-linked glycans by negative ion tandem mass spectrometry and confirmation of glycans containing galactose attached to the bisecting (beta1-4-GlcNAc) residue in N-glycans from IgG." Rapid Commun Mass Spectrom 22(7): 1047-1052.



Hecht, R. and G. Gandhi (2008). "Demand forecasting for preventive AIDS vaccines: economic and policy dimensions." Pharmacoeconomics 26(8): 679-697.



Huang, Y., A. Chen, X. Li, Z. Chen, W. Zhang, Y. Song, D. Gurner, D. Gardiner, S. Basu, D. D. Ho and M. Tsuji (2008). "Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide." Vaccine 26(15): 1807-1816.



Jaoko, W., F. N. Nakwagala, O. Anzala, G. O. Manyonyi, J. Birungi, A. Nanvubya, F. Bashir, K. Bhatt, H. Ogutu, S. Wakasiaka, L. Matu, W. Waruingi, J. Odada, M. Oyaro, J. Indangasi, J. Ndinya-Achola, C. Konde, E. Mugisha, P. Fast, C. Schmidt, J. Gilmour, T. Tarragona, C. Smith, B. Barin, L. Dally, B. Johnson, A. Muluubya, L. Nielsen, P. Hayes, M. Boaz, P. Hughes, T. Hanke, A. McMichael, J. Bwayo and P. Kaleebu (2008). "Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa." Vaccine 26(22): 2788-2795.




Karlsson Hedestam, G. B., R. A. Fouchier, S. Phogat, D. R. Burton, J. Sodroski and R. T. Wyatt (2008). "The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus." Nat Rev Microbiol 6(2): 143-155.



Kempf, M. C., S. Allen, I. Zulu, N. Kancheya, R. Stephenson, I. Brill, A. Tichacek, A. Haworth, E. Chomba and H. I. V. R. G. Rwanda Zambia (2008). "Enrollment and retention of HIV discordant couples in Lusaka, Zambia." J Acquir Immune Defic Syndr 47(1): 116-125.




Koff, W. C., C. L. Parks, B. Berkhout, J. Ackland, S. Noble and I. D. Gust (2008). "Replicating viral vectors as HIV vaccines Summary Report from IAVI Sponsored Satellite Symposium, International AIDS Society Conference, July 22, 2007." Biologicals 36(5): 277-286.



Laird, M. E., T. Igarashi, M. A. Martin and R. C. Desrosiers (2008). "Importance of the V1/V2 loop region of simian-human immunodeficiency virus envelope glycoprotein gp120 in determining the strain specificity of the neutralizing antibody response." J Virol 82(22): 11054-11065.



Law, M. and L. Hangartner (2008). "Antibodies against viruses: passive and active immunization." Curr Opin Immunol 20(4): 486-492.



Lin, Y. A., J. M. Chalker, N. Floyd, G. J. Bernardes and B. G. Davis (2008). "Allyl sulfides are privileged substrates in aqueous cross-metathesis: application to site-selective protein modification." J Am Chem Soc 130(30): 9642-9643.



Lingappa, J. R., B. Lambdin, E. A. Bukusi, K. Ngure, L. Kavuma, M. Inambao, W. Kanweka, S. Allen, J. N. Kiarie, J. Makhema, E. Were, R. Manongi, D. Coetzee, G. de Bruyn, S. Delany-Moretlwe, A. Magaret, N. Mugo, A. Mujugira, P. Ndase, C. Celum and H. S. V. H. I. V. T. S. G. Partners in Prevention (2008). "Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial." PLoS One 3(1): e1411.



Mansfield, K., S. M. Lang, M. C. Gauduin, H. B. Sanford, J. D. Lifson, R. P. Johnson and R. C. Desrosiers (2008). "Vaccine protection by live, attenuated simian immunodeficiency virus in the absence of high-titer antibody responses and high-frequency cellular immune responses measurable in the periphery." J Virol 82(8): 4135-4148.



McElrath, M. J., S. C. De Rosa, Z. Moodie, S. Dubey, L. Kierstead, H. Janes, O. D. Defawe, D. K. Carter, J. Hural, R. Akondy, S. P. Buchbinder, M. N. Robertson, D. V. Mehrotra, S. G. Self, L. Corey, J. W. Shiver, D. R. Casimiro and T. Step Study Protocol (2008). "HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis." Lancet 372(9653): 1894-1905.



Mehendale, S., J. van Lunzen, N. Clumeck, J. Rockstroh, E. Vets, P. R. Johnson, P. Anklesaria, B. Barin, M. Boaz, S. Kochhar, J. Lehrman, C. Schmidt, M. Peeters, C. Schwarze-Zander, K. Kabamba, T. Glaunsinger, S. Sahay, M. Thakar, R. Paranjape, J. Gilmour, J. L. Excler, P. Fast and A. E. Heald (2008). "A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine." AIDS Res Hum Retroviruses 24(6): 873-880.



Menendez, A., D. A. Calarese, R. L. Stanfield, K. C. Chow, C. N. Scanlan, R. Kunert, H. Katinger, D. R. Burton, I. A. Wilson and J. K. Scott (2008). "A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120." FASEB J 22(5): 1380-1392.



Nelson, J. D., H. Kinkead, F. M. Brunel, D. Leaman, R. Jensen, J. M. Louis, T. Maruyama, C. A. Bewley, K. Bowdish, G. M. Clore, P. E. Dawson, S. Frederickson, R. G. Mage, D. D. Richman, D. R. Burton and M. B. Zwick (2008). "Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics." Virology 377(1): 170-183.



Nicolaou, K. C., T. R. Wu, D. Sarlah, D. M. Shaw, E. Rowcliffe and D. R. Burton (2008). "Total synthesis, revised structure, and biological evaluation of biyouyanagin A and analogues thereof." J Am Chem Soc 130(33): 11114-11121.



Pacheco, B., S. Basmaciogullari, J. A. Labonte, S. H. Xiang and J. Sodroski (2008). "Adaptation of the human immunodeficiency virus type 1 envelope glycoproteins to new world monkey receptors." J Virol 82(1): 346-357.



Pantophlet, R., T. Wrin, L. A. Cavacini, J. E. Robinson and D. R. Burton (2008). "Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificity." Virology 381(2): 251-260.



Peters, P. J., I. Zulu, N. G. Kancheya, S. Lakhi, E. Chomba, C. Vwalika, D. J. Kim, I. Brill, J. Meinzen-Derr, A. Tichacek, S. A. Allen and H. I. V. R. G. Rwanda Zambia (2008). "Modified Kigali combined staging predicts risk of mortality in HIV-infected adults in Lusaka, Zambia." AIDS Res Hum Retroviruses 24(7): 919-924.



Phogat, S., K. Svehla, M. Tang, A. Spadaccini, J. Muller, J. Mascola, I. Berkower and R. Wyatt (2008). "Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles." Virology 373(1): 72-84.



Pugach, P., T. J. Ketas, E. Michael and J. P. Moore (2008). "Neutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitors." Virology 377(2): 401-407.



Reynolds, M. R., A. M. Weiler, K. L. Weisgrau, S. M. Piaskowski, J. R. Furlott, J. T. Weinfurter, M. Kaizu, T. Soma, E. J. Leon, C. MacNair, D. P. Leaman, M. B. Zwick, E. Gostick, S. K. Musani, D. A. Price, T. C. Friedrich, E. G. Rakasz, N. A. Wilson, A. B. McDermott, R. Boyle, D. B. Allison, D. R. Burton, W. C. Koff and D. I. Watkins (2008). "Macaques vaccinated with live-attenuated SIV control replication of heterologous virus." J Exp Med 205(11): 2537-2550.



Sandstrom, E., C. Nilsson, B. Hejdeman, A. Brave, G. Bratt, M. Robb, J. Cox, T. Vancott, M. Marovich, R. Stout, S. Aboud, M. Bakari, K. Pallangyo, K. Ljungberg, B. Moss, P. Earl, N. Michael, D. Birx, F. Mhalu, B. Wahren, G. Biberfeld and H. I. V. I. S. Team (2008). "Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara." J Infect Dis 198(10): 1482-1490.



Sato, S., E. Yuste, W. A. Lauer, E. H. Chang, J. S. Morgan, J. G. Bixby, J. D. Lifson, R. C. Desrosiers and W. E. Johnson (2008). "Potent antibody-mediated neutralization and evolution of antigenic escape variants of simian immunodeficiency virus strain SIVmac239 in vivo." J Virol 82(19): 9739-9752.



Scanlan, C. N., D. R. Burton and R. A. Dwek (2008). "Making autoantibodies safe." Proc Natl Acad Sci U S A 105(11): 4081-4082.



Stephenson, R., J. Barker, R. Cramer, M. A. Hall, E. Karita, E. Chomba, C. Vwalika and S. Allen (2008). "The demographic profile of sero-discordant couples enrolled in clinical research in Rwanda and Zambia." AIDS Care 20(3): 395-405.




Stephenson, R., E. Mendenhall, L. Muzizi, B. Vwalika, E. Chomba, Y. Ahmed, L. Clark, D. Roth, J. Telfair, A. Haworth and S. Allen (2008). "The influence of motivational messages on future planning behaviors among HIV concordant positive and discordant couples in Lusaka, Zambia." AIDS Care 20(2): 150-160.



Stephenson, R., E. Shutes, S. McKenna, S. Allen, I. Brill, N. Kancheya, I. Zulu, M. Sinkala, A. Tichacek and E. Chomba (2008). "The impact of project closure on HIV incidence and mortality in a cohort of couples in Lusaka, Zambia." AIDS Care 20(6): 683-691.



Stevens, W., A. Kamali, E. Karita, O. Anzala, E. J. Sanders, W. Jaoko, P. Kaleebu, J. Mulenga, L. Dally, P. Fast, J. Gilmour, B. Farah, J. Birungi, P. Hughes, O. Manigart, G. Stevens, S. Yates, H. Thomson, A. von Lieven, M. Krebs, M. A. Price, L. Stoll-Johnson and N. Ketter (2008). "Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials." PLoS One 3(4): e2043.



Tang, J., W. Shao, Y. J. Yoo, I. Brill, J. Mulenga, S. Allen, E. Hunter and R. A. Kaslow (2008). "Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples." J Immunol 181(4): 2626-2635.



Thorne, B. A., P. Quigley, G. Nichols, C. Moore, E. Pastor, D. Price, J. W. Ament, R. K. Takeya and R. W. Peluso (2008). "Characterizing clearance of helper adenovirus by a clinical rAAV1 manufacturing process." Biologicals 36(1): 7-18.



van Griensven, F. and E. J. Sanders (2008). "Understanding HIV risks among men who have sex with men in Africa." Sex Transm Dis 35(4): 355-356.



Walker, B. D. and D. R. Burton (2008). "Toward an AIDS vaccine." Science 320(5877): 760-764.



Wang, S., J. S. Kennedy, K. West, D. C. Montefiori, S. Coley, J. Lawrence, S. Shen, S. Green, A. L. Rothman, F. A. Ennis, J. Arthos, R. Pal, P. Markham and S. Lu (2008). "Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers." Vaccine 26(8): 1098-1110.



Wang, S. K., P. H. Liang, R. D. Astronomo, T. L. Hsu, S. L. Hsieh, D. R. Burton and C. H. Wong (2008). "Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN." Proc Natl Acad Sci U S A 105(10): 3690-3695.



Watkins, D. I., D. R. Burton, E. G. Kallas, J. P. Moore and W. C. Koff (2008). "Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans." Nat Med 14(6): 617-621.



Yuste, E., J. Bixby, J. Lifson, S. Sato, W. Johnson and R. Desrosiers (2008). "Glycosylation of gp41 of simian immunodeficiency virus shields epitopes that can be targets for neutralizing antibodies." J Virol 82(24): 12472-12486.